๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Fas and fas ligand expression in esophageal squamous cell carcinoma

โœ Scribed by rigberg, D.A.; Centeno, J.; Kim, F.S.; Cole, M.A.; Swenson, K.; Maggard, M.; McFadden, D.W.

Book ID
123211329
Publisher
Elsevier Science
Year
1998
Tongue
English
Weight
148 KB
Volume
114
Category
Article
ISSN
0016-5085

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

Irradiation-induced up-regulation of Fas
Irradiation-induced up-regulation of Fas in esophageal squamous cell carcinoma is not accompanied by Fas ligand-mediated apoptosis
โœ Rigberg, David A.; Centeno, Joseph; Kim, Frances S.; Ke, Bibo; Swenson, Kim; Mag ๐Ÿ“‚ Article ๐Ÿ“… 1999 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 155 KB ๐Ÿ‘ 2 views

Background and Objectives: Fas (APO-1) induces apoptosis after binding Fas ligand (FasL). Evidence suggests that tumors may use this interaction to evade the host immune response. Fas/FasL expression has not been reported in esophageal cancer. We hypothesized that Fas expression would render esophag

Fas ligand expression in esophageal carc
Fas ligand expression in esophageal carcinomas and their lymph node metastases
โœ Mamoun Younes; Mary R. Schwartz; Atilla Ertan; Delia Finnie; Anas Younes ๐Ÿ“‚ Article ๐Ÿ“… 2000 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 178 KB ๐Ÿ‘ 1 views

## BACKGROUND. Although esophageal adenocarcinomas (EADCA) have been shown to have substantially reduced or absent Fas expression, the status of Fas ligand (FasL) in these tumors, especially adenocarcinomas, is largely unknown. ## METHODS. Using immunohistochemistry, the authors investigated FasL